ONE YEAR REAL-WORLD OUTCOMES FOLLOWING NON-MEDICAL SWITCHING FROM STELARA® TO PYZCHIVA® IN CROHN'S DISEASE: DRUG PERSISTENCE, DISEASE CONTROL AND PHARMACOKINETICS (UEGW 2026) - Sep 28, 2026 - Abstract #LBP12; Pres time: Oct 18, 2026; 09:00 AM - 06:00 PM; Location: Hall 7 Poster Area; "Full abstract will be published on the day of presentation"
Clinical • Late-breaking abstract • PK/PD data • Real-world • Real-world evidence • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease
|
|
L. Cudero 1; D. Rafael de la Cruz Esteban 1; L. Guerrero 2; C. Moreno Giraud 1; A. Navascués Lucini 1; A. Suárez-Saro Fernández 1; C. García Muñoz 1; F. López Romero-Salazar 1; A. Masedo Gonzalez 1; C. Yela San Bernardino 1; B. Casis Herce 1; M. Algara San Nicolas 1; Y. González Lama 1
|